These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23499583)

  • 21. [Expression and single nucleotide polymorphisms of kallikrein 10 in colorectal cancer].
    Feng B; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Qu Y; Li JW; Lu AG; Wang ML; Liu BY; Zhu ZG
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):623-7. PubMed ID: 16784657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uncovering the clinical impact of kallikrein-related peptidase 5 (KLK5) mRNA expression in the colorectal adenoma-carcinoma sequence.
    Papachristopoulou G; Malachias A; Devetzi M; Kamouza E; Scorilas A; Xynopoulos D; Talieri M
    Clin Chem Lab Med; 2019 Jul; 57(8):1251-1260. PubMed ID: 30759066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of kallikrein‑related peptidase 5 is associated with the malignant behavior of colorectal cancer.
    Wu Y; Chen Y; Li Q; Gong Y; Liu X; Bi L; Hu C
    Mol Med Rep; 2016 Sep; 14(3):2164-70. PubMed ID: 27430713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kallikreins as markers of disseminated tumour cells in ovarian cancer-- a pilot study.
    Oikonomopoulou K; Scorilas A; Michael IP; Grass L; Soosaipillai A; Rosen B; Murphy J; Diamandis EP
    Tumour Biol; 2006; 27(2):104-14. PubMed ID: 16557045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
    Michaelidou K; Ardavanis A; Scorilas A
    Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression analysis and study of KLK4 in benign and malignant breast tumours.
    Papachristopoulou G; Avgeris M; Scorilas A
    Thromb Haemost; 2009 Feb; 101(2):381-7. PubMed ID: 19190825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantified KLK15 gene expression levels discriminate prostate cancer from benign tumors and constitute a novel independent predictor of disease progression.
    Mavridis K; Stravodimos K; Scorilas A
    Prostate; 2013 Aug; 73(11):1191-201. PubMed ID: 23620432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
    Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
    Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Wang H; Zhang X; Wang L; Zheng G; Du L; Yang Y; Dong Z; Liu Y; Qu A; Wang C
    J Surg Oncol; 2014 May; 109(6):574-9. PubMed ID: 24338523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression and prognostic role of selected genes in colorectal cancer patients.
    Pitule P; Vycital O; Bruha J; Novak P; Hosek P; Treska V; Hlavata I; Soucek P; Kralickova M; Liska V
    Anticancer Res; 2013 Nov; 33(11):4855-65. PubMed ID: 24222123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.
    Yousef GM; White NM; Michael IP; Cho JC; Robb JD; Kurlender L; Khan S; Diamandis EP
    Tumour Biol; 2005; 26(5):227-35. PubMed ID: 16103744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer.
    Stavropoulou P; Gregorakis AK; Plebani M; Scorilas A
    Clin Chim Acta; 2005 Jul; 357(2):190-5. PubMed ID: 15893744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma.
    Foteinou E; Kontos CK; Giotakis AI; Scorilas A
    Biol Chem; 2014 Sep; 395(9):1051-62. PubMed ID: 24854539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100P, a potential novel prognostic marker in colorectal cancer.
    Wang Q; Zhang YN; Lin GL; Qiu HZ; Wu B; Wu HY; Zhao Y; Chen YJ; Lu CM
    Oncol Rep; 2012 Jul; 28(1):303-10. PubMed ID: 22552710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
    Sidiropoulos M; Pampalakis G; Sotiropoulou G; Katsaros D; Diamandis EP
    Tumour Biol; 2005; 26(6):324-36. PubMed ID: 16254462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients.
    Svoboda M; Slyskova J; Schneiderova M; Makovicky P; Bielik L; Levy M; Lipska L; Hemmelova B; Kala Z; Protivankova M; Vycital O; Liska V; Schwarzova L; Vodickova L; Vodicka P
    Carcinogenesis; 2014 Jul; 35(7):1510-5. PubMed ID: 24583926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
    J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma.
    Rückert F; Hennig M; Petraki CD; Wehrum D; Distler M; Denz A; Schröder M; Dawelbait G; Kalthoff H; Saeger HD; Diamandis EP; Pilarsky C; Grützmann R
    Br J Cancer; 2008 Nov; 99(9):1484-92. PubMed ID: 18854834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.